ATE135210T1 - 2-oxindol-1-carboxamidderivat enthaltendes arzneimittel zur rektalen verabreichung - Google Patents

2-oxindol-1-carboxamidderivat enthaltendes arzneimittel zur rektalen verabreichung

Info

Publication number
ATE135210T1
ATE135210T1 AT92105712T AT92105712T ATE135210T1 AT E135210 T1 ATE135210 T1 AT E135210T1 AT 92105712 T AT92105712 T AT 92105712T AT 92105712 T AT92105712 T AT 92105712T AT E135210 T1 ATE135210 T1 AT E135210T1
Authority
AT
Austria
Prior art keywords
rectal administration
oxindol
product containing
carboxamide derivative
medicinal product
Prior art date
Application number
AT92105712T
Other languages
English (en)
Inventor
Walter Fries
Guenther Dr Pfaff
Carl Joerg Pfitzner
Gerhard Dr Simon
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Application granted granted Critical
Publication of ATE135210T1 publication Critical patent/ATE135210T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT92105712T 1991-04-08 1992-04-02 2-oxindol-1-carboxamidderivat enthaltendes arzneimittel zur rektalen verabreichung ATE135210T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4111305A DE4111305C2 (de) 1991-04-08 1991-04-08 Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält

Publications (1)

Publication Number Publication Date
ATE135210T1 true ATE135210T1 (de) 1996-03-15

Family

ID=6429051

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92105712T ATE135210T1 (de) 1991-04-08 1992-04-02 2-oxindol-1-carboxamidderivat enthaltendes arzneimittel zur rektalen verabreichung

Country Status (7)

Country Link
EP (1) EP0508310B1 (de)
JP (1) JPH05112527A (de)
AT (1) ATE135210T1 (de)
DE (2) DE4111305C2 (de)
DK (1) DK0508310T3 (de)
ES (1) ES2084204T3 (de)
GR (1) GR3019968T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
DK0680321T3 (da) * 1993-01-22 1999-06-14 Pfizer Lysinsalt af 6-chlor-5-fluor-3-(2-thenoyl)-2-oxindol-1-carboxamid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Also Published As

Publication number Publication date
JPH05112527A (ja) 1993-05-07
DE4111305A1 (de) 1992-10-15
ES2084204T3 (es) 1996-05-01
EP0508310B1 (de) 1996-03-13
DE69208913T2 (de) 1996-07-25
GR3019968T3 (en) 1996-08-31
DK0508310T3 (da) 1996-06-10
DE69208913D1 (de) 1996-04-18
DE4111305C2 (de) 1994-12-01
EP0508310A1 (de) 1992-10-14

Similar Documents

Publication Publication Date Title
ATE494009T1 (de) Prodrugs, ihre herstellung und verwendung als arzneimittel
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
IL108873A0 (en) 2-debenzoyl-2-acyl taxol derivatives, pharmaceutical compositions containing the same, and methods for the preparation thereof
FR2678938B1 (fr) Derives de pyrrolidine, leur preparation et les medicaments les contenant.
EP0614373A4 (de) Orale pharmazeutische Zusammensetzungen, die ein Polyethylenglykol-ImmunglobulinKonjugat enthält.
IL104158A0 (en) Bicyclotridecenone compounds,their preparation and pharmaceutical compositions containing them
FI933477A0 (fi) Monohydrat av ett dinatriumsalt av 4-klorfenyltiometylenbisfosfonsyra,dess framstaellning och farmaceutiska kompositioner innehaollande detta
ATE135210T1 (de) 2-oxindol-1-carboxamidderivat enthaltendes arzneimittel zur rektalen verabreichung
EP0535250A4 (en) Novel compounds and use thereof as medicine
DE69214710D1 (de) Dirithromycin enthaltendes Arzneimittel
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
IL106289A0 (en) Phospholipid derivatives, their preparation and pharmaceutical compositions containing them
ATE208203T1 (de) Multiantioxidant enthaltendes arzneimittel
ATE131049T1 (de) Injizierbare 2-oxindol-1-carboxamidderivate enthaltende arzneizubereitungen.
AU658197B2 (en) New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
DK0626173T3 (da) Aerosolpræparat indeholdende fusafungin
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
IL89015A (en) Pharmaceutical compositions containing tetrahydropyridine derivatives, certain such novel compounds and their preparation
DE69434010D1 (de) C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen
NZ239055A (en) Spiro((ox or thi)azoline-piperidine or -quinuclidine) derivatives and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee